PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.07 - 0.07
0.04 - 0.15
230.0K / 2.59M (Avg.)
-2.37 | -0.03
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.37%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-20.11%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-28.33%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-29.83%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
7.11%
Positive net income growth while 8070.HK is negative. John Neff might see a big relative performance advantage.
6.33%
EPS growth under 50% of 8070.HK's 22.33%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
6.33%
Diluted EPS growth under 50% of 8070.HK's 22.33%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-15.52%
Negative 10Y revenue/share CAGR while 8070.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-36.82%
Negative 5Y CAGR while 8070.HK stands at 136.30%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-40.84%
Negative 3Y CAGR while 8070.HK stands at 150.25%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
738.15%
OCF/share CAGR of 738.15% while 8070.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
66.25%
3Y OCF/share CAGR under 50% of 8070.HK's 854.62%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-8.55%
Negative 10Y net income/share CAGR while 8070.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-881.13%
Negative 5Y net income/share CAGR while 8070.HK is 215.84%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-879.87%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
-25.09%
Negative 5Y equity/share growth while 8070.HK is at 60.74%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
66.77%
3Y equity/share CAGR at 75-90% of 8070.HK's 76.31%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-23.54%
We cut SG&A while 8070.HK invests at 7.67%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.